NewGenIvf (NIVF) EPS (Basic) (2024 - 2025)
NewGenIvf (NIVF) posted quarterly EPS (Basic) of -$503.21 for Q4 2025, up 96.29% year-over-year from -$256.36 in Q4 2024, and down 114.98% quarter-over-quarter from $3359.3 in Q3 2025.
NewGenIvf (NIVF) EPS (Basic) (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported EPS (Basic) for 2 consecutive years, with -$503.21 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 96.29% year-over-year to -$503.21; the TTM figure through Dec 2025 stood at $558.38 (up 103.97% YoY), while the FY2025 annual figure was $523.14, up 102.51% from the prior year.
- EPS (Basic) declined to -$503.21 in Q4 2025 per NIVF's latest filing, from $3359.3 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3359.3 in Q3 2025 and bottomed at -$13567.1 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 8.75 |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 9.89 |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -0.01 |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 5.30 |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 1.72 |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 6.01 |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 0.48 |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 5.14 |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 0.54 |
| 10 | NewGenIvf | 9,048.24 | -1.43 Mn | 524,025.00 | -503.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -503.21 |
| Sep 30, 2025 | 3,359.30 |
| Dec 31, 2024 | -13,567.10 |
| Sep 30, 2024 | -0.35 |